A Phase II Clinical Trial to Evaluate the Immunogenicity and Reactogenicity of the Recombinant HIV-1 Envelope Vaccines SF-2 rgp120 (CHO) [Chiron Vaccines] in MF59 Adjuvant and MN rgp120/HIV-1 [VaxGen] in Alum Adjuvant in Healthy Adults

Name: A Phase II Clinical Trial to Evaluate the Immunogenicity and Reactogenicity of the Recombinant HIV-1 Envelope Vaccines SF-2 rgp120 (CHO) [Chiron Vaccines] in MF59 Adjuvant and MN rgp120/HIV-1 [VaxGen] in Alum Adjuvant in Healthy Adults
License: Public Domain

National Institute of Allergy and Infectious Diseases (NIAID)

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

hiv infections

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 350000
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.